Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $11.88 USD
Change Today -0.22 / -1.82%
Volume 30.8K
TTOO On Other Exchanges
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John P. McDonough

Chief Executive Officer, President and Director,T2 Biosystems, Inc.
AgeTotal Calculated CompensationThis person is connected to 32 board members in 4 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. John P. McDonough has been the Chief Executive Officer and President of T2 Biosystems, Inc. since November 2011. Mr. McDonough joined T2 Biosystems in November, 2007. Prior to joining T2, Mr. McDonough served as the President of Cytyc Development Corporation and had responsibility for designing and executing Cytyc Corporation’s acquisition and investment strategy for growing the company from a single product company with revenue of approximately $300 million in 2003 ...

Read Full Background

Corporate Headquarters*

101 Hartwell Avenue
Lexington, Massachusetts 02421

United States

Phone: 718-491-3400
Fax: 781-357-3080

Board Members Memberships*

Chief Executive Officer, President and Director


Unknown/Other Education 1981
Stonehill College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$380,369

Stock Options*

Exercisable Options408,361
Unexercisable Options251,929
Total Number of Options660,290

Total Compensation*

Total Annual Cash Compensation$645,994
Total Short Term Compensation$380,369
Total Calculated Compensation$1,245,364
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TTOO:US $11.88 USD -0.22


Hany Massarany Chief Executive Officer, President and Director
GenMark Diagnostics, Inc.
Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
John A. Krauetler Chairman of The Board, Chief Executive Officer and President
Meridian Bioscience, Inc.
Michael K. McGarrity Chief Executive Officer, President and Director
Nanosphere, Inc.
Ryan Ashton Co-Founder, Chief Executive Officer, President and Director
Great Basin Scientific, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact T2 BIOSYSTEMS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at